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Abstract
Objectives: In this study, we evaluate the incidence of and analyse the pre and intraoperative risk factors for the development of
postoperative renal dysfunction (PRD), and the impact of such an event on perioperative mortality and on hospital length of stay. In addition,
we sought to investigate the influence of a mildly increased serum creatinine (1.3–2.0 mg/dl) on perioperative mortality and morbidity.
Methods: The study included 2445 consecutive patients who had no pre-existing renal disease (creatinine#2.0 mg/dl, without dialysis) and
who underwent isolated coronary surgery under cardiopulmonary bypass between July 1996 and December 2001. The main outcome
measure was PRD, defined as a postoperative serum creatinine level $2.1 mg/dl with a preoperative-to-postoperative increase $0.9 mg/dl.
Univariate and multivariate analyses were performed where appropriate. Results: Global 30-day mortality was 0.7%. The incidence of PRD
was 5.6% (136 patients). Mortality for patients who experienced PRD was 8.8 vs. 0.1% for patients who did not ðP , 0:001Þ: PRD increased
the length of hospital stay by 3.4 days (7.6 vs. 11.0 days; P , 0:001), and patients who needed haemodialysis (11%) had a perioperative
mortality of 33.3% and a mean hospital length of stay of 16 days. Multivariable logistic regression identified the following variables as
independent predictors of PRD: age (P ¼ 0:017; odds ratio (OR) 1.3 per 10 years), angina class III/IV (P ¼ 0:003; OR 1.7); cardiopulmonary
bypass time (P ¼ 0:007; OR 1.01 per minute); preoperative serum creatinine levels: group 1 (1.3–1.6 mg/dl (P , 0:001; OR 5.5)) and group
2 (1.7–2.0 mg/dl (P , 0:001; OR 14.2)). Finally, a mild elevation of the preoperative creatinine level (1.3–2.0 mg/dl) increased
significantly the probability of perioperative mortality, low cardiac output, haemodialysis and prolonged hospital stay. Conclusions:
Although the likelihood of PRD in patients without pre-existing renal dysfunction is relatively low, it dramatically increases mortality,
morbidity and length of stay after CABG. Mildly elevated (.1.2 mg/dl) preoperative serum creatinine level significantly increases the
perioperative mortality and morbidity.
q 2004 Published by Elsevier B.V.
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1. Introduction
Acute changes in renal function after coronary bypass
surgery are not well understood and incompletely charac-
terised, and represent a challenging clinical problem. Many
reports have described the results of coronary surgery in
patients with end-stage renal disease [1–5], but, there have
been a limited number of studies reporting the outcome of
patients with mild or moderate renal dysfunction not on
dialysis [6–9]. Yet, the proportion of patients with this
clinical status is much higher than that of patients with
dialysis-dependent renal failure, hence it is important to
identify and characterise the risk in this subgroup of
patients.
The first objective of this study was to evaluate the
incidence of postoperative renal dysfunction (PRD) and
analyse the pre and intraoperative risk factors for the
development of this complication, and its impact on
perioperative mortality and on hospital length of stay. The
second objective was to evaluate the influence of a mildly
increased creatinine serum level (1.3–2.0 mg/dl) on perio-
perative mortality and morbidity.
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2. Patients and methods
2.1. Patient selection
A total of 2445 patients who had no significant pre-
existing renal disease (creatinine #2.0 mg/dl and without
dialysis) and who underwent isolated coronary surgery
under cardiopulmonary bypass between July 1996 and
December 2001 were recruited to the study. The data of
these patients were prospectively collected in a dedicated
data-base.
The highest serum creatinine level within the 2 days
preceding the operation was taken as the preoperative
creatinine level, which was not normally distributed, with a
median of 1.0 mg/dl and an interquartile range of
0.8–1.1 mg/dl. The postoperative creatinine level was the
highest in-hospital postoperative value and it was measured
in all patients for a minimum of 2 days after peak values
were reached to confirm that levels were decreasing.
The main outcome measure in this study was PRD,
defined as a postoperative creatinine serum level
$2.1 mg/dl plus an increase in the serum creatinine level
$0.9 mg/dl from preoperative to maximum postoperative
values (values rounded off to 0.1 mg/dl). The criteria for
choosing these values were derived from the distribution of
serum creatinine levels in an uncomplicated subset of
patients. This subset excluded patients with a complicated
perioperative course (in-hospital death, intra-aortic balloon
pump or other mechanical assist device, use of inotropic
drugs, reoperation for haemorrhage or sternal compli-
cations, respiratory failure, myocardial infarction, and
prolonged hospital postoperative stay). Of the 2122 patients
meeting these criteria only 5% had a maximum post-
operative creatinine level $2.1 mg/dl and a maximum
preoperative-to-postoperative change in creatinine level of
0.9 mg/dl or greater (Table 1).
2.2. Clinical variables
The demographic variables studied as potential risk
factors for PRD and considered for inclusion in all the
multivariable analyses performed were: age, sex, height,
weight, body mass index (weight divided by height square),
and body surface area. The clinical and laboratory variables
evaluated were cardiomegaly, cerebral vascular disease,
peripheral vascular disease, chronic obstructive pulmonary
disease, anemia, recent tobacco use, diabetes mellitus,
history of hypertension, dislipidemia, unstable angina,
angina class (Canadian Cardiovascular Society), prior
heart surgery, recent myocardial infarction, serum creati-
nine level (mg/dl) and surgical priority (elective, urgent,
emergent). Defenitions for variables are listed in
Appendix A.
For risk analysis of PRD, the preoperative creatinine
serum was dived into two groups: Group 1—values above
the upper limit of our institution’s normal range of 1.2 mg/dl
but equal to or less than 1.6 mg/dl, defined as mild
elevation; Group 2—elevation to 1.7 mg/dl or above, and
defined as moderate elevation. Accordingly, 228 patients
(9.3%) had a creatinine level of 1.3–1.6 mg/dl, and 43
(1.8%) had a creatinine level of 1.7–2.0 mg/dl. The
remaining 2174 patients (89.0%) had preoperative serum
creatinine levels of less than 1.3 mg/dl.
Operative mortality was defined as death within 30 days
of the operation or during the same hospitalisation. An in-
hospital stay above the 90th percentile was defined as
prolonged, equalling a postoperative stay of 10 days or
greater. Low cardiac output syndrome (LCOS) was defined
as the need for postoperative intra-aortic balloon pump
and/or inotropic support, for any length of time, in the
intensive care unit. Creatinine clearance was estimated from
serum creatinine, age, weight and gender by the of
Cockcroft and Gault’s formula.
2.3. Surgical technique for CABG
Cardiopulmonary bypass was conducted with non-
pulsatile flow and mild hypothermia (32 8C), and the
systemic perfusion pressure was electively maintained at
55–65 mmHg. A left ventricular vent was always intro-
duced through the right superior pulmonary vein and left
atrium. All operations were performed under ventricular
fibrillation without cardioplegia, a technique described in
detail in previous reports [10,11]. The mean number of
grafts per patient was 2.8 ^ 0.8, and the mean cardiopul-
monary bypass time was 61.3 ^ 20.1 min. A bloodless
prime was used in more than 95% of the cases, whenever the
preoperative haematocrit was greater than 35%, and blood
was not administered unless it fell bellow 20–22% during
cardiopulmonary bypass. Collected mediastinal blood shed
during the first 6 postoperative hours was reinfused
manually.
2.4. Statistical analysis
Distributions and univariate measures of preoperative,
postoperative, and preoperative-to-postoperative changes in
serum creatinine values were examined. Models were
analysed in a piece-wise fashion (separate models were
developed for each preoperative and operative period from
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the significant unadjusted factors in each period). A final
model with adjusted estimates was derived with factors that
remained significant in the two-time-period models [12].
Operative variables were entered into the model in a
forward stepwise fashion after adjustment for preoperative
variables. The best-fitting models were selected from
evaluation of the Hosmer–Lemeshow goodness-of-fit and
Omnibus test statistic. The predictive ability of the models
were also evaluated by the area under the curve of the
receiving operating characteristic (ROC).
3. Results
3.1. Postoperative renal dysfunction
3.1.1. Incidence and risk analysis
PRD, as defined above, occurred in 136 (5.6%) of the
2445 patients in our study, 15 of whom (11.0, 0.6% of all
study patients) required haemodialysis.
The distribution of serum creatinine values in the 2122
patients with an uncomplicated postoperative course shows
that there was an increase in the median of 0.3 mg/dl between
the preoperative (1.0 mg/dl) and the maximum postoperative
(1.3 mg/dl) values with a range of 11.4 mg/dl (20.7 to
10.4 mg/dl). Using the Cockcroft and Gault formula, this
corresponds to a median reduction of 20 ml/min on the
estimated creatinine clearance between preoperative
(82 ml/min) and postoperative (62 ml/min) values.
Table 2 shows the final model of risk factors for PRD.
Patients with a preoperative creatinine level of 1.3–1.6 mg/dl
were 5.5 times as likely ðP , 0:001Þ to develop PRD as patients
with a preoperative creatinine level of less than 1.3 mg/dl, and
patients with a preoperative creatinine level of 1.7 mg/dl or
greater were 14 times as likely to have such a result ðP ,
0:001Þ: The other preoperative variables identified by multi-
variable logistic regression to be independent predictors of PRD
were increasing age (P ¼ 0:015; OR 1.3 per 10 years), and
angina class III/IV (P ¼ 0:003; OR 1.7). Cardiopulmonary
bypass time was the only operative variable identified-for each
extra 10 min, the likelihood of PRD increased by a factor of 1.14
ðP ¼ 0:007Þ: The model utilised demonstrated a good
calibration and discriminatory power (Hosmer–Lemeshow
test: x2 ¼ 11:58; df ¼ 8, P ¼ 0:171; mean ROC area of 0.75
(95% confidence interval ¼ 0.70–0.79)).
3.1.2. Mortality and postoperative hospital stay
Global 30-day mortality was 0.7, 8.8% for patients who
experienced PRD vs. 0.1% for patients who did not
ðP , 0:001Þ: The mortality rate was 5.8% (7 of 114
patients) in patients with renal dysfunction who did not
require dialysis and 33.3% (5 of 15 patients) among those
who required dialysis.
Occurrence of PRD increased the length of hospital stay
by 3.4 days (7.6 vs. 11.0 days; P , 0:001) and patients who
needed haemodialysis (11%) had a mean hospital stay of
16.0 ^ 12.8 days.
3.2. Influence of a mildly (1.3–2.0 mg/dl) increased
preoperative serum creatinine levels on mortality
and morbidity
The influence of the preoperative creatinine serum values
on mortality and morbidity (need for new renal function
support-haemodialysis-, LCOS, cerebrovascular accident,
delirium, reoperation for haemorrhage or for sternal
complications, myocardial infarction, and prolonged hospi-
tal stay) was also analysed.
Of the 2445 patients in the study, 271 (11.1%) had a
preoperative serum creatinine level equal to or greater than
1.3 mg/dl. A comparative univariate analysis of the
preoperative and operative data of this patient group with
that of the group of patients with a normal preoperative
creatinine level ðn ¼ 2:174Þ; is shown in Table 3.
By multivariable analysis, the mortality was 3.3 times
ðP ¼ 0:031Þ higher if the preoperative creatinine level rose
to 1.3 mg/dl or greater (because the number of events was
low, it was not possible to subdivide into small groups).
Other factors contributing to increased mortality were the
presence of cerebrovascular disease (OR 4.4; P ¼ 0:025)
and cardiomegaly (OR 3.5; P ¼ 0:023) (Table 4).
Of the 2445 patients in the study, 15 (0.6%) required
postoperative haemodialysis. Comparing with patients with
a normal preoperative creatinine level, those with a level of
Table 2
Final model of risk factors for PRD
Covariate Variable estimate SE P-value Odds ratio IC95% (OR)
Age 0.028 0.012 0.015 1.03 1.01 1.05
Angina class III/IV 0.541 0.187 0.004 1.72 1.19 2.48
Preoperative creatinine level (mg/dl)
Group 1 (1.3–1.6) 1.704 0.214 ,0.001 5.49 3.62 8.36
Group 2 ($1.7) 2.630 0.341 ,0.001 13.87 7.10 27.07
CPB time 0.013 0.005 0.007 1.01 1.00 1.02
Constant 26.127 0.851 ,0.001
CPB, Cardiopulmonary bypass.
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1.3 mg/dl or greater had an increased risk of 4.5 times for
necessitating postoperative haemodialysis. The other inde-
pendent risk factors identified were anaemia ðP , 0:001Þ
and angina class III/IV ðP ¼ 0:035Þ (Table 5).
LCOS occurred in 171 patients (7.0%). Multivariate
analysis showed that the group of patients with a higher
preoperative creatinine level had a significantly increased
risk of developing LCOS. The other factors that increased
the likelihood of developing this syndrome are shown in
Table 6.
A postoperative stay of 10 days or longer was required in
194 patients (7.9%). By multivariable analysis, patients with a
preoperative creatinine level of 1.3 mg/dl or greater had a
nearly 2-fold likelihood of a prolonged postoperative hospital
stay (OR 1.7; P ¼ 0:017). Other factors contributing to a
prolonged hospital stay were increasing age (OR 1.035 per
year; P ¼ 0:002), peripheral vascular disease (OR 1.7;
P ¼ 0:020), angina class III/IV (OR 1.6; P ¼ 0:003), and
use of double internal thoracic artery (OR 2.5; P , 0:001)
(Table 7).
The preoperative serum creatinine level was not found to
be a significant predictor of cerebrovascular accident,
delirium, reoperation for haemorrhage or for sternal
complications, and myocardial infarction.
4. Discussion
4.1. Postoperative renal dysfunction: incidence,
risk analysis and outcomes
The causes of renal dysfunction after coronary surgery
are multifactorial and usually attributed to the use of
cardiopulmonary bypass, cardiovascular compromise, or
toxic insults to the kidneys. Non-pulsatile flow, renal
hypoperfusion, hypothermia, and duration of CPB are also
thought to have adverse effects on renal function. Hence, it
is to be expected that during and/or after surgery, even if
uncomplicated, one might find some deterioration of the
renal function. In this study, which included 2122 patients
with a preoperative creatinine serum level #2.0 mg/dl and
uncomplicated postoperative course, there was a mean
increase of 0.3 mg/dl between preoperative (1.0 mg/dl) and
maximum postoperative serum creatinine levels
(1.3 mg/dl), and a reduction of 20 ml/min in the estimated
creatinine clearance from pre (82 ml/min) to postoperative
(62 ml/min) values. Similar results were reported by
Ascione and Swaminathan and their associates [13,14]
who have shown a 20% reduction in creatinine clearance
after coronary surgery with CPB.
The precise level at which preoperative subclinical renal
dysfunction begins to adversely affect outcome is unknown.
Table 3
Univariate analysis of preoperative and operative significant risk factors of
patients with normal (,1.3 mg/dl) and elevated (1.3–2.0 mg/dl) preopera-
tive creatinine serum level





Age (years) 65.5 ^ 8.3 60.4 ^ 9.0 ,0.001
Body surface area (cm2) 179.2 ^ 13.1 176.9 ^ 14.4 0.011
Female sex 7.0 14.1 0.001
Hypertension 67.2 57.7 0.002
Dislipidemia 52.4 59.6 0.024
Peripheral vascular disease 13.3 8.0 0.004
Cerebrovascular disease 8.5 4.1 0.001
Anaemia 5.9 3.3 0.027
Cardiomegaly 16.6 10.5 0.003
Unstable angina 14.0 6.8 ,0.001
Angina CCS class III or IV 44.7 36.6 ,0.010
LV dysfunction (EF , 0.4) 20.7 11.4 ,0.001
No. of grafts (mean/pt) 2.9 ^ 0.7 2.8 ^ 0.8 0.012
a Unless otherwise specified, values are in percentage.
Table 4
Factors contributing significantly toward increased perioperative mortality
Covariate Variable estimate SE P-value Odds ratio IC95% (OR)
Preoperative creatinine $1.3 mg/dl 1.025 0.559 0.031 3.34 1.11 9.99
Cardiomegaly 1.265 0.557 0.023 3.54 1.19 10.55
Cerebrovascular disease 1.482 0.662 0.025 4.40 1.20 16.14
Constant 25.751 0.375 ,0.001
Table 5
Factors contributing significantly toward the need for postoperative haemodialysis
Covariate Variable estimate SE P-value Odds ratio IC95% (OR)
Preoperative creatinine $1.3 mg/dl 1.508 0.565 0.008 4.52 1.49 13.68
Anaemia 2.295 0.655 ,0.001 9.92 2.75 35.79
Angina class III/IV 1.304 0.618 0.035 3.68 1.10 12.37
Constant 28.915 1.348 ,0.001
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Some studies [6–9] attempting to address this issue looked
at the effect of elevations of preoperative serum creatinine
levels varying from 1.5 to 2.5 mg/dl, and found a significant
negative influence of these values on perioperative mortality
and morbidity. However, the effect of a more borderline
elevation of preoperative serum creatinine levels
(1.3–2.0 mg/dl), as we address in this study, has not been
investigated in a large cohort multivariable model.
The reported incidence of renal dysfunction after
cardiac surgery is significantly influenced by the
definition used in a given study. Most studies previously
published used only absolute creatinine values, while
others used widely differing change criteria; this yielded
incidences of dysfunction ranging from 0.9 to 29%
[15–18,23]. As in the study by Mangano and associates
[19], we sought to overcome this limitation by deriving
the criteria for dysfunction from the distribution of serum
creatinine values in an uncomplicated subset of patients
and by defining PRD on the basis of an absolute
creatinine value ($2.1 mg/dl) coupled with a relative
change in creatinine level ($0.9 mg/dl) between the
preoperative and the postoperative periods.
By multivariate analysis of the putative risk factors for
the development of PRD in association with coronary
surgery, we have identified higher preoperative serum
creatinine levels as the strongest factor. When compared
to preoperative creatinine levels of less than 1.3 mg/dl,
levels of 1.3–1.6 mg/dl and of 1.7 mg/dl or greater
increased the likelihood of developing PRD by 5.5 and
14 times, respectively. These results are in accordance with
those previously reported by others [6–8,20–24] and
confirm a significant influence of even minor elevations of
preoperative creatinine serum levels on postoperative renal
function. Because they probably have a greater proportion
of functionally borderline glomeruli, patients with higher
preoperative serum creatinine levels, are potentially more
susceptible to deterioration of their renal function when
exposed to a perioperative insult. The probability of
developing PRD was also seen to be significantly greater
in older patients, those with more advanced angina class and
with increased cardiopulmonary bypass times. These
risk variables have also been identified by other groups
[19,22,23,25].
In the present study, the mortality rate of patients with
PRD was significantly higher than in patients without PRD
(8.8 vs. 0.1%). Additionally, we report a markedly increased
mortality rate among patients with PRD who required
dialysis (33.3 vs. 5.8%). These results are in accordance
with others previously reported which also confirm the
negative impact of PRD, especially among those who
required dialysis, on perioperative mortality [1–5,18,19,
26]. In addition, as it was also reported by others [9,19,21],
this study showed that PRD increased significantly the
length of hospital stay (7.6 vs. 11.0 days), even
more prolonged in patients who needed haemodialysis
(16.0 days).
4.2. Influence of a mildly increased (1.3–2.0 mg/dl)
preoperative serum creatinine levels on mortality
and morbidity
The current study highlighted a pronounced impact of the
preoperative creatinine values on mortality, by showing that
the effect is significant even at mild elevations of the
preoperative serum creatinine values. The perioperative
mortality was significantly increased (3.3 times) in the
group of patients with a mildly increased (1.3–2.0 mg/dl)
preoperative creatinine serum level. Further differences
Table 6
Factors contributing significantly to the development of LOCS
Covariate Variable estimate SE P-value Odds ratio IC95% (OR)
Preoperative creatinine $1.3 mg/dl 0.509 0.234 0.030 1.66 1.05 2.63
LV dysfunction (FE , 40%) 1.089 0.191 ,0.001 2.97 2.04 4.32
Non-elective surgery 0.982 0.282 ,0.001 2.67 1.54 4.64
ECC time 0.015 0.005 0.002 1.02 1.01 1.02
Constant 22.443 1.375 ,0.001
Table 7
Factors contributing significantly toward prolonged postoperative hospital stay
Covariate Variable estimate SE P-value Odds ratio IC95% (OR)
Preoperative creatinine $1.3 mg/dl 0.512 0.206 0.013 1.67 1.12 2.50
Age 0.035 0.011 0.001 1.04 1.01 1.06
Peripheral vascular disease 0.582 0.223 0.009 1.79 1.16 2.77
Angina class III/IV 0.494 0.154 0.001 1.64 1.21 2.22
Double IMA 0.841 0.209 ,0.001 2.32 1.54 3.49
Constant 25.151 0.691 ,0.001
IMA, internal mammary artery.
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could be demonstrated for different levels within this range.
Patients with creatinine levels of 1.3–1.6 mg/dl and
.1.6 mg/dl had a perioperative mortality of 1.8 and 2.9%,
respectively (Fig. 1).
The VA Cooperative Study database demonstrated that
patients with a preoperative serum creatinine level of
1.5–3 mg/dl had increased 30-day mortality after coronary
surgery [26]. In a recent study, Weerasinghe et al. [8] also
found a significant increase in the in-hospital mortality in
patients with creatinine values $1.5 mg/dl.
We have also uncovered that a mild preoperative
creatinine elevation was an independent risk factor for
some morbidity events. Comparing with patients with a
normal preoperative creatinine level, those with a level of
1.3 mg/dl or greater had a 4.5-fold increased risk of
necessitating postoperative haemodialysis, had an almost
2-fold increased risk of developing LCOS, and a 2-fold
increased likelihood of a prolonged hospital stay.
4.3. Study limitations
We have studied an unselected cohort of CABG patients
that enabled the documentation of 136 cases of PRD and
allowed the creation of a statistically powerful regression
model to identify pre and intraoperative predictors of PRD
in patients subjected to isolated coronary surgery. However,
the present study has limitations that include those inherent
to any retrospective analysis, even when data were colleted
prospectively, as was the case. Another weakness of this
study is related to the method used for detection of renal
dysfunction. Serum creatinine was chosen because of the
simplicity of measurement. Ideally, creatinine clearance, a
well-established indicator of glomerular filtration rate,
should be measured to assess renal function, since serum
creatinine levels are influenced by body surface area and
body water mass. But creatinine clearance is not routinely
measured in our patients subjected to elective CABG.
5. Conclusion
PRD, which occurred in 5.6% of the 2445 patients
subjected to isolated CABG, proved to be an important
complication, carrying a significant morbidity and a
mortality of 8.8%. Four preoperative and operative risk
factors for PRD were identified: age, angina class III/IV,
creatinine serum level and cardiopulmonary bypass time.
Among these, elevations in preoperative serum creatinine
levels were the stronger risk factors for PRD. Identification
of the risk factors for PRD may constitute valuable
information for preoperative risk stratification and to
facilitate patient selection and/or optimisation. This study
also confirms that the morbidity and mortality are increased
in coronary surgery patients with a slightly elevation of the
preoperative serum creatinine level.
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Diabetes mellitus History of diabetes treated with oral
agents or insulin
Hypertension Blood pressure exceeding
140/90 mmHg, or a history of high
blood pressure, or the need of
antihypertensive medications
Dislipidemia History of hypercholesterolemia
and/or hypertrigliceridemia




Manifested by one or more of:
exertional claudication and/or rest
pain, prior revascularisation procedure
to the lower limbs, absent or
diminished pulses in the legs,
angiographic evidence of non-
iatrogenic peripheral arterial




Previous stroke and/or transient
ischemic attack
Anaemia Haematocrit #34%
COPD Resulting in one or more of: functional
disability, hospitalisation, requirement
of chronic bronchodilator therapy,
FEV1 , 75% of predicted
Cardiomegaly A cardiothoracic ratio .0.50
demonstrated on a preoperative chest
film
Recent AMI Evidence of AMI in the last 30 days
before surgery
Unstable angina Use of intravenous nitrates within 48 h
of surgery
LV dysfunction Left ventricular ejection fraction
,40%
Appendix B. Conference discussion
Dr P. Sergeant (Leuven, Belgium): I understand very clearly how you
have made your event definition based on this very nice presentation, in fact
how you selected, so it was not totally arbitrarily.
Dr Antunes: No, it wasn’t.
Dr Sergeant: It is very clear that the interval between 1.5 and 2.0 mg/dl
is a critical span whereby there is nearly an exponential increase if you go
from 1.5 to 2.0. Are you not a little bit depressed by the fact that you have
just made this crude cut-off of 2.0 and wouldn’t it have been nicer if you
would have identified, for example, 1.5.
Dr Antunes: This may always be subject to criticism. Traditionally,
creatinine levels greater than 2.0 are considered renal dysfunction. Several
authors have made similar studies, but they used arbitrarily the values of
1.5. We have studied in our own population without complications the
distribution of creatinine levels. That is why we came up with 2.1, with a
postoperative variation of 0.9, and those were the factors that we used then
for our inclusion criteria. You can’t use any values.
To our surprise, however, when we started analysing the results and
when we went back to see lower values, even values above 1.2, which in our
laboratory is upper limit of normal, even those values had an influence on
postoperative outcome.
So the main message, if I can take a message out of this paper, is that
even those patients which are just marginally above normal, carry a major
influence in the postoperative outcome with regards not only to the
appearance of significant renal dysfunction but also of other complications,
morbidity and mortality and the prolonged length of stay.
Dr N. Wang (Loma Linda, California): I am just curious, in our
study of ischemic cardiomyopathy patients, mitral regurgitation seems
to have a significant impact on renal function, in other words, whether
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they are reoperations or first time operation, renal function is poor in
patients with mitral regurgitation. Did you find a similar kind of
observation?
Dr Antunes: I followed your paper with a lot of interest, but
unfortunately, mitral valve regurgitation was not one of the variables that
we included in this study. We may go back and see if it does, but we did not
use that variable. These 28 variables were those that we predicted could
make a difference in the outcome. We didn’t consider mitral regurgitation.
It is perhaps a shortcoming. So I am unable to give you any information on
that.
Dr M. Guida (Valencia, Venezuela): I would like to know your opinion
about the role of the pump as an operative risk factor on the basis of the
comparison of both groups, on-pump and off-pump.
Dr Antunes: We do not do routinely off-pump surgery. We do an
average of 5 or 6% of our cases off-pump, and this was not studied. We
deliberately included just patients done on-pump. The only thing I can tell
you, as it was shown, is that the duration of cardiopulmonary bypass
increased the morbidity, the mortality and the incidence of renal
dysfunction by a factor of 1.14 for each 10 min of cardiopulmonary bypass
time. So even if the values are relatively low, 61 min as a mean, it is
important to keep it as short as possible.
Dr M. Albreht (Lafayette, Colorado): It appears that the duration of
cardiopulmonary bypass is a risk factor for renal failure postoperatively.
Has it been pulsatile in all patients or a continuous flow pump?
Dr Antunes: We use a continuous non-pulsatile flow, yet the incidence
of PRD, as seen here, was 5.6, which is the usual incidence that other
authors describe for other methods of cardiopulmonary bypass.
Mr K. Rammohan (Cardiff, UK): We also have an interest in this and
have just started to look at something along these lines. I was curious to see
what you presented about anaemia being a predictive factor. Do you have
any numbers on that, and what thereafter would be a transfusion trigger in
ITU? Do you address these people differently, because as I am sure you are
aware, there was something very recently in the literature as well about this.
Dr Antunes: The definitions for each one of those variables will come in
the manuscript. We considered patients with an Hb lower than 12 g, and
usually they wouldn’t be of any concern to us. In fact, we only use blood in
less than 7.5% of our patients because of the non-cardioplegic method.
This is a finding that we have with this study. Obviously we will take all
the consequences from these findings and we will look into that more
carefully in the future handling of these patients postoperatively.
Because we are concerned about the use of blood, we have allowed our
haematocrit values to come to about 20% and then gradually go up during
the postoperative stay as we remove fluids from the patients.
Dr L. Testolin (Padova, Italy): In the subset of patients which includes
the preoperative risk factors you identified, did you use intraoperative
ultrafiltration or any kind of modified ultrafiltration to prevent this
complication?
Dr Antunes: No, we don’t. As I indicated, we use a non-cardioplegic
method, and we try to avoid overloading the patient as much as possible.
We use mannitol going on bypass, and if it goes over 45 min we will give
another 12.5 g, so it will be either 12.5 or 25 g, and then we will use Lasix.
We are often proud to say to our students who visit us that we use the
patient’s kidney as an ultrafiltration device. We have used a device in a few
patients, but we don’t use it routinely now.
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